Related Experiment Video
Updated: May 22, 2026

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
Targeting NADPH oxidases for the treatment of cancer and inflammation
Michael Y Bonner1, Jack L Arbiser
1Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract:
NADPH oxidases are a family of oxidases that utilize molecular oxygen to generate hydrogen peroxide and superoxide, thus indicating physiological functions of these highly reactive and short-lived species. The regulation of these NADPH oxidases (nox) enzymes is complex, with many members of this family exhibiting complexity in terms of subunit composition, cellular location, and tissue-specific expression. While the complexity of the nox family (Nox1-5, Duox1, 2) is daunting, the complexity also allows for targeting of NADPH oxidases in disease states. In this review, we discuss which inflammatory and malignant disorders can be targeted by nox inhibitors, as well as clinical experience in the use of such inhibitors.
Insights
NADPH oxidases (nox) generate reactive oxygen species. This review explores targeting nox enzymes with inhibitors for inflammatory and malignant disorders, discussing clinical experiences.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- NADPH oxidases (nox) are enzymes utilizing molecular oxygen to produce hydrogen peroxide and superoxide.
- These reactive species have crucial physiological roles, but their dysregulation is implicated in disease.
- The nox family (Nox1-5, Duox1-2) exhibits complex regulation, subunit composition, localization, and expression patterns.
Purpose of the Study:
- To review the targeting of NADPH oxidases in disease states.
- To discuss specific inflammatory and malignant disorders amenable to nox inhibition.
- To summarize clinical experiences with nox inhibitors.
Main Methods:
- Literature review of NADPH oxidase function and regulation.
- Analysis of studies investigating nox inhibitors in disease models.
- Compilation of clinical trial data and case reports on nox inhibitor use.
Main Results:
- NADPH oxidases play roles in various inflammatory and malignant conditions.
- The complexity of the nox family allows for specific therapeutic targeting.
- Clinical data on nox inhibitors, while emerging, shows potential.
Conclusions:
- NADPH oxidases represent promising therapeutic targets for inflammatory and malignant diseases.
- Further research and clinical trials are needed to optimize nox inhibitor therapies.
- Targeting nox enzymes offers a potential strategy for novel disease treatments.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Peroxisomes

